CPBIO Holding Company Limited (3839.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap235.93M
Enterprise Value243.97M
P/E Ratio9.76
PEG Ratio-2.96
Price/Sales Ratio0.54
Price/Book Ratio0.77
Enterprise/Revenue0.63
Enterprise/EBITDA6.82

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.06
Operating Margin0.07
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.09

Income Statement

Revenue536.71M
Revenue/Share1.76
Gross Profit77.55M
EBITDA48.38M
Net Income32.1M
Diluted EPS0.13

Balance Sheet

Total Cash37.25M
Total Cash/Share0.15
Total Debt75.56M
Total Debt/Equity0.26
Current Ratio1.6
Book Value Per Share1.36

Price History

52-Week Change5.71
52-Week High9.89
52-Week Low5.5
Moving Average 50 Days8.04
Moving Average 200 Days7.93

Statistics

Average Volume46,180
Shares Outstanding240.72M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A
AD